Frank Bruzzese

Frank Bruzzese has a diverse and extensive work experience in the field of scientific research. Frank has recently worked as a Principal Scientist at Tango Therapeutics since 2022. Prior to that, they worked as a Scientist II Biochemistry Biophysics at Casma Therapeutics from 2018 to 2022. Frank also has significant experience working as a Scientist at Millenium/ Takeda Pharmaceuticals from 2004 to 2017, where they specialized in elucidating molecular mechanisms and protein-ligand interactions. Their expertise includes antibody-receptor characterization, small molecule immune modulator binding studies, and the development of biochemical assays for various protein families.

Frank Bruzzese has a Master of Science degree in Biophysics from SUNY Binghamton and a Bachelor of Science degree in Chemistry from Syracuse University.